Christopher Geiler Md is categorized under Internal Medicine Practitioners in Santa Barbara, CA and active since 1998.
Christopher Geiler Md was established in 1998, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Christopher Geiler at the company’s single location by writing to 536 East Arrellaga St # 203, Santa Barbara, California CA 93103 or by phoning (805) 962-3667. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Christopher Geiler Md |
Contact Person: | Christopher Geiler |
Address: | 536 East Arrellaga St # 203, Santa Barbara, California 93103 |
Phone Number: | (805) 962-3667 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Christopher Geiler Md was started in 1998 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher Geiler for inquiries that concern Christopher Geiler Md by calling the company number (805) 962-3667, as your correspondence is most welcome. Additionally, the physical location of the single location of Christopher Geiler Md can be found at the coordinates 34.433617,-119.70244 as well as the street address 536 East Arrellaga St # 203 in Santa Barbara, California 93103.
For its online presence, you may visit Christopher Geiler Md’s website at and engage with its social media outlets through on Twitter and on Facebook.